AQR Capital Management »

Actinium Pharmaceuticals shares owned by AQR Capital Management

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $676k 359k 1.88

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Actinium Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
Acadian Asset Management
AQR Capital Management
Northern Trust
Thomas Stevens, CFA"
Verition Fund Management
Nuveen Asset Management
Renaissance Technologies
Morgan Stanley
Brandywine Global Investment Management
Citadel Advisors

View all funds holding Actinium Pharmaceuticals